| Product Code: ETC12838580 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Influenza Medications Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Influenza Medications Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Influenza Medications Market - Industry Life Cycle |
3.4 Vietnam Influenza Medications Market - Porter's Five Forces |
3.5 Vietnam Influenza Medications Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Vietnam Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Vietnam Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
4 Vietnam Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of influenza cases in Vietnam |
4.2.2 Growing awareness about the importance of early treatment of influenza |
4.2.3 Rising healthcare expenditure in Vietnam |
4.3 Market Restraints |
4.3.1 Stringent regulatory approvals for new influenza medications |
4.3.2 High competition among existing influenza medication providers in Vietnam |
5 Vietnam Influenza Medications Market Trends |
6 Vietnam Influenza Medications Market, By Types |
6.1 Vietnam Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Influenza Medications Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Vietnam Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2021 - 2031F |
6.1.4 Vietnam Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2021 - 2031F |
6.2 Vietnam Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Influenza Medications Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Vietnam Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2021 - 2031F |
6.2.4 Vietnam Influenza Medications Market Revenues & Volume, By Inhalation, 2021 - 2031F |
6.3 Vietnam Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Influenza Medications Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Vietnam Influenza Medications Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Vietnam Influenza Medications Market Revenues & Volume, By Geriatric, 2021 - 2031F |
7 Vietnam Influenza Medications Market Import-Export Trade Statistics |
7.1 Vietnam Influenza Medications Market Export to Major Countries |
7.2 Vietnam Influenza Medications Market Imports from Major Countries |
8 Vietnam Influenza Medications Market Key Performance Indicators |
8.1 Number of prescriptions for influenza medications |
8.2 Rate of adoption of new and innovative influenza medications |
8.3 Patient adherence to prescribed influenza treatment plans |
9 Vietnam Influenza Medications Market - Opportunity Assessment |
9.1 Vietnam Influenza Medications Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Vietnam Influenza Medications Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Vietnam Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
10 Vietnam Influenza Medications Market - Competitive Landscape |
10.1 Vietnam Influenza Medications Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here